Skip to main content
Veterinary Medicines

Vetmedin 5 mg - Kapseln für Hunde

Authorised
  • Pimobendan

Product identification

Medicine name:
Vetmedin 5 mg - Kapseln für Hunde
Active substance:
  • Pimobendan
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pimobendan
    5.00
    milligram(s)
    /
    1.00
    Capsule
Pharmaceutical form:
  • Capsule, hard
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC01CE90
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Klocke Pharma-Service GmbH
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00446
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/02/2019
Updated on: 5/03/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/02/2019
Updated on: 5/03/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/02/2019
Updated on: 5/03/2025

at-puar-600000072590-np-vetmedin-de.pdf

German (PDF)
Published on: 16/09/2019
Updated on: 5/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."